SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-067666
Filing Date
2024-06-03
Accepted
2024-06-03 08:34:42
Documents
1
Period of Report
2024-05-31

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3390
  Complete submission text file 0000950170-24-067666.txt   4885
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Issuer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ATYR PHARMA, INC. 10240 SORRENTO VALLEY ROAD, SUITE 300 SAN DIEGO CA 92121
Business Address
Shukla Sanjay (Reporting) CIK: 0001671026 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37378 | Film No.: 241012095